Pharmaceutical Industry Blog

Why Farbe Firma is the Leading Injectable Manufacturer in the Bahamas Last Updated: 15 September 2026 TL;DR: The Bahamas has no product registration or marketing authorisation regime for medicines. The Pharmacy Act, 2009, consolidated as Chapter 227, runs to 52 sections and creates no drug register and no dossier assessment. What it creates instead is a pharmacopoeia standard and a premises-and-person licensing system run by the Bahamas Pharmacy Council. The Bahamas National

Why Farbe Firma is the Leading Injectable Manufacturer in Belize Last Updated: 15 September 2026 TL;DR: Belize has no standalone medicines agency. Authorisation sits with the Director of Health Services inside the Ministry of Health and Wellness, and the operative instrument is the Food and Drugs (Registration, Licensing and Inspection) Regulations 2017, S.I. No. 54 of 2017. That instrument requires genuine product registration rather than a bare import permit, and it names n

Last Updated: September 14, 2026 TL;DR: Brunei Darussalam's governing instrument is the Medicines Order, 2007, and product registration has been mandatory since July 2012 — but we found no reference-country list published by the authority itself. The benchmark list that circulates comes from a trade guide, and India is not among the countries it names, so India's absence is reported rather than verified. The best-evidenced requirement is the import licence: the applicant must

Last Updated: September 14, 2026 TL;DR: The Maldives Food and Drug Authority publishes a named list of Reference Regulatory Authorities in Annexure-I of its Guideline on Good Reliance Practice. We read all 45 entries and India is not among them, though MFDA itself describes the list as dynamic and subject to change. Reliance pathways are mandatory for parenterals; a WHO-GMP certificate issued by an Indian state licensing authority is not one of the enumerated grounds for exem

Last Updated: September 13, 2026 TL;DR: Cabo Verde's medicines regulator is ERIS, created by Decreto-Lei n.º 03/2019 de 10 de janeiro, which extinguished ARFA — so any guidance naming ARFA is stale. ERIS publishes two reference-entity lists and India's CDSCO is on neither by name. Its only possible entry runs through WHO's maturity-level list, where WHO's scope for CDSCO reads Vaccines (producing). The full dossier route is open, and the recognition rules set WHO GMP equivale

Last Updated: September 13, 2026 TL;DR: Suriname has no standalone medicines agency. Marketing authorisation is granted by the Registratiecommissie der geneesmiddelen, which the Ministry of Health calls a working organ of the Ministry of Health, under an Ordinance of 8 May 1896 that is still operative as amended. Its fast track names eleven countries and four further categories, and India is not among them. The full dossier route stays open — on paper, in Dutch or English, fi